Výsledky vyhledávání - "Steven E. Vogl"

Adjuvant ovarian suppression for resected breast cancer: 2017 critical assessment

Autor: Steven E. Vogl

Publikováno v: Breast cancer research and treatment. 166(1)

Currently available data supporting adjuvant ovarian function suppression for resected breast cancer in premenopausal women in addition to standard chemotherapy and tamoxifen are not persuasive, even though an ASCO guideline supports them. Available

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48182fe54a576f9d7d9e858ee95d5e9
https://pubmed.ncbi.nlm.nih.gov/28695299

Zobrazit plný text záznamu

Phase II Study of Mitoguazone, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone for Patients with Diffuse Histologic Subtypes of Non-Hodgkin's Lymphoma: An Eastern Cooperative Oncology Group Study (PE481)

Autor: Dirk F. Moore, Martin M. Oken, Selina M. Luger, Steven E. Vogl, John M. Bennett, John H. Glick, Jules E. Harris, Peter H. Wiernik

Publikováno v: Leukemia & Lymphoma. 30:601-607

Mitoguazone, an investigational agent with significant activity in advanced lymphoma, was added to a modified CHOP regimen (COPA) in an effort to improve the activity of standard therapy in 66 previously untreated patients with stages II-IV lymphoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67741778515a3225c15f1c841491c8f5
https://doi.org/10.3109/10428199809057572

Zobrazit plný text záznamu

Plný text ve formátu HTML

High-Dose Megestrol Acetate in the Treatment of Patients With Ovarian Cancer Who Have Undergone Previous Treatment

Autor: James A. Young, Edward Greenwald, Steven E. Vogl, Peter H. Wiernik, Harrison Ball

Publikováno v: American Journal of Clinical Oncology. 21:565-567

High-dose megestrol acetate has been reported to be effective salvage therapy for women with ovarian carcinoma. The Eastern Cooperative Oncology Group performed this phase II study of oral megestrol acetate, 200 mg four times daily until disease prog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed71e73b371f766c012c014f042f4ca
https://doi.org/10.1097/00000421-199812000-00007

Zobrazit plný text záznamu

Myeloma of the head of the pancreas. A case report

Autor: Ariel Fischer, Mark J. Suhrland, Steven E. Vogl

Publikováno v: Cancer. 67:681-683

A 45-year-old man was diagnosed with multiple myeloma, IgA-kappa, in 1975. Thirteen years later he presented with obstructive jaundice. Computed tomography (CT) showed a 6-cm mass in the head of the pancreas. Needle aspiration showed myeloma. The jau

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0575decda7e6808d06cd4a30eea545af
https://doi.org/10.1002/1097-0142(19910201)67:3<681::aid-cncr2820670325>3.0.co

Zobrazit plný text záznamu

Characterization of patients who received further adjuvant endocrine therapy after 5 years of aromatase inhibitors (AIs): NCIC CTG MA 27

Autor: Liting Zhu, Paul E. Goss, Judy-Anne W. Chapman, Lois E. Shepherd, Steven E. Vogl, Abdullah Altwairgi

Publikováno v: Journal of Clinical Oncology. 30:e11005-e11005

e11005 Background: MA.27 examined the efficacy of 5 yrs of adjuvant aromatase inhibitors (AI), exemestane and anastrozole. Long term outcomes of AI trials may be influenced by unspecified subsequent hormonal therapy so we enquired about its frequency

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::503653cd21302faf4ffb37ef6705a477
https://doi.org/10.1200/jco.2012.30.15_suppl.e11005

Zobrazit plný text záznamu

Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group

Autor: Barry H. Kaplan, Eugene Fazzini, T. E. Davis, Geoffrey Falkson, Brigitte Cheuvart, Beow Y. Yeap, Robert L. Comis, Peter H. Wiernik, Steven E. Vogl, John Horton

Publikováno v: Cancer investigation. 10(1)

A total of 248 analyzable patients with Stages III-IV ovarian epithelial cancer (114 with and 134 without prior chemotherapy) were randomized to one of four cisplatin (DDP)-hexamethylmelamine (HMM) regimens. In each, HMM, 200 mg/m2 was given orally d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2255adbf2f6bc10ebf70bb2116101c6
https://pubmed.ncbi.nlm.nih.gov/1735009

Zobrazit plný text záznamu

A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study

Autor: Dennis L. Citrin, John C. Marsh, Donald L. Trump, Steven E. Vogl, Richard G. Hahn, Larry K. Kvols, T. E. Davis

Publikováno v: Investigational new drugs. 8

Twenty-nine patients with metastatic prostate cancer progressing after hormonal therapy (orchiectomy 19, diethylstilbestrol 10) and who had never received cytotoxic therapy were treated with carboplatin. Patients had good clinical performance status

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca5159fba06d8f6c06a6d5ddd4e7035
https://pubmed.ncbi.nlm.nih.gov/2199402

Zobrazit plný text záznamu

Methotrexate alone or with regional subcutaneous corynebacterium parvum in the treatment of recurrent and metastatic squamous cancer of the head and neck

Autor: John Horton, Harvey J. Lerner, Barry H. Kaplan, Richard H. Creech, Steven E. Vogl, Leon Barnes, David A. Schoenfeld

Publikováno v: Cancer. 50:2295-2300

Patients with advanced, incurable squamous cancer of the head and neck were randomly assigned to treatment with weekly methotrexate alone or methotrexate with Corynebacterium parvum given subcutaneously in weekly bilateral doses in sites around the n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bea16c04e52b681e5cfab15a7d33b501
https://doi.org/10.1002/1097-0142(19821201)50:11<2295::aid-cncr2820501113>3.0.co

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání